Harvard Gastroenterology 2024

Description

The Comprehensive 2024 Gastroenterology Update

Date : June 10 – 13, 2024

Overview

This program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.

Practical, Results-Driven Education

Highlights of the 2024 program include:

Updated guidelines for the use of biologics in IBD
Therapeutic drug monitoring in IBD treatment
Management of the older adult with IBD
Updated guidelines for treatment of C. difficile infection
Managing GI complications of immunotherapy
Improved management of IBS
Tips to managing fecal incontinence
Management of refractory GERD
Expanded genetic testing options to diagnose hereditary GI cancer syndromes
Management of fatty liver disease in 2024
How to diagnose and manage cirrhosis
How to improve your adenoma detection rate (ADR)
Steps to ensure delivery of high-quality colonoscopic care
Techniques to effectively control acute GI bleeding
Endoscopic management of obesity
When FMT is indicated for treatment
Impact of COVID on the GI tract
New strategies to treat common GI problems
A comprehensive update of national guidelines

As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.

Education to Optimize Your Patient Outcomes

The evidence-based recommendations provided in this program cover:

IBD
GI Complications of Immunotherapy
Microscopic Colitis
Fatty Liver
Barrett’s Esophagus
Eosinophilic Esophagitis
C. difficile Colitis
Alcohol-Related Liver Disease
Autoimmune Hepatitis
IBS
Refractory GERD
Acute Pancreatitis
Chronic Pancreatitis
Celiac Disease
GI Bleeding
High Risk for Colorectal Cancer

Recent Advances and Innovations

Clinicians can rely on this program for education on:

Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
Managing refractory pouchitis
GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?
The stool microbiome: understanding the science behind clinical applications
Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon
Adenoma detection rates: critical to measure and how to incorporate strategies, including AI, to increase your rate
Endoscopic approaches to managing obesity

This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.

Who Should Attend

Gastroenterologists
Internists
Surgeons
Nurse Practitioners
Physician Assistants

11 reviews for Harvard Gastroenterology 2024

David Chen, PharmD, BCPS, Clinical Pharmacy, Phoenix, AZ

Rated 5 out of 5

"The pharmacotherapy content is superb. Detailed, evidence-based reviews of biologic therapies for IBD, anticoagulation management for endoscopy, and ...More
"The pharmacotherapy content is superb. Detailed, evidence-based reviews of biologic therapies for IBD, anticoagulation management for endoscopy, and novel treatments for motility disorders are essential for my collaborative role."

Helpful? 0 0

Jonathan Reid, RD, CNSC, Nutrition Support, Portland, OR

Rated 5 out of 5

"An excellent update on the medical and surgical aspects of nutrition. The sessions on intestinal failure, short bowel syndrome, and parenteral nutrit...More
"An excellent update on the medical and surgical aspects of nutrition. The sessions on intestinal failure, short bowel syndrome, and parenteral nutrition management provide crucial context for my work on the nutrition support team."

Helpful? 0 0

Dr. Aaron Wilcox, Emergency Medicine, Philadelphia, PA

Rated 5 out of 5

"Highly relevant for the ED. The workup of GI bleeding, abdominal pain, and acute liver failure is covered with a depth and clarity that directly info...More
"Highly relevant for the ED. The workup of GI bleeding, abdominal pain, and acute liver failure is covered with a depth and clarity that directly informs critical management decisions in the acute setting."

Helpful? 0 0

Dr. Irene Kostas, Oncologist, Cleveland, OH

Rated 5 out of 5

"Essential for any oncologist. Understanding the management of GI toxicities from immunotherapy and chemotherapy, as well the surveillance of Barrett'...More
"Essential for any oncologist. Understanding the management of GI toxicities from immunotherapy and chemotherapy, as well the surveillance of Barrett's esophagus and IBD, is a critical part of providing comprehensive cancer care."

Helpful? 0 0

Dr. Robert Yi, Surgical Oncologist, New York, NY

Rated 5 out of 5

"Incredibly valuable for a surgeon. The detailed preoperative endoscopic and medical optimization of patients with esophageal, pancreatic, and hepatob...More
"Incredibly valuable for a surgeon. The detailed preoperative endoscopic and medical optimization of patients with esophageal, pancreatic, and hepatobiliary cancers enhances multidisciplinary collaboration and improves patient outcomes."

Helpful? 0 0

Amara Johnson, NP, Gastroenterology Clinic, Atlanta, GA

Rated 5 out of 5

"As an NP in a busy GI practice, this course provides the deep, nuanced understanding I need to manage complex patients independently. The lectures on...More
"As an NP in a busy GI practice, this course provides the deep, nuanced understanding I need to manage complex patients independently. The lectures on the GI manifestations of systemic disease were particularly insightful."

Helpful? 0 0

Dr. Samuel Cohen, Advanced Endoscopist, Denver, CO

Rated 5 out of 5

"Harvard continues to set the standard. The interventional endoscopy updates, including techniques and management of adverse events, are cutting-edge....More
"Harvard continues to set the standard. The interventional endoscopy updates, including techniques and management of adverse events, are cutting-edge. The high-quality video clips integrated into the lectures are incredibly valuable."

Helpful? 0 0

Priya Sharma, MD, Internal Medicine, Chicago, IL

Rated 5 out of 5

"This course empowers the general internist to manage common GI complaints with greater confidence. The algorithms for IBS, GERD, and abnormal LFTs ar...More
"This course empowers the general internist to manage common GI complaints with greater confidence. The algorithms for IBS, GERD, and abnormal LFTs are immediately applicable to my practice and improve patient triage and referral decisions."

Helpful? 0 0

Dr. Ben Carter, GI Fellow (PGY-5), Baltimore, MD

Rated 5 out of 5

"This is the ultimate board and in-service exam prep tool. The way complex physiology is broken down—especially in the motility and pancreaticobiliary...More
"This is the ultimate board and in-service exam prep tool. The way complex physiology is broken down—especially in the motility and pancreaticobiliary sections—is genius. The ability to rewatch lectures on Google Drive is a massive advantage."

Helpful? 0 0

Marcus Thorne, Hepatologist, Los Angeles, CA

Rated 5 out of 5

"The liver disease sections are worth the price of admission alone. Comprehensive updates on MASLD/MASH (formerly NAFLD/NASH), AIH, and managing compl...More
"The liver disease sections are worth the price of admission alone. Comprehensive updates on MASLD/MASH (formerly NAFLD/NASH), AIH, and managing complications of portal hypertension were presented with unparalleled clarity. A must for any hepatology practice."

Helpful? 0 0

Dr. Eleanor Vance, Gastroenterologist, Boston, MA

Rated 5 out of 5

"An exceptional annual update. The 2024 sessions on the management of complex IBD patients, including the use of newer biologics and navigating post-o...More
"An exceptional annual update. The 2024 sessions on the management of complex IBD patients, including the use of newer biologics and navigating post-operative scenarios, were incredibly practical and evidence-based. The digital slides are a fantastic reference."

Helpful? 0 0

Add a review